☆ 3.8 Article

Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study

HEMATOLOGY REPORTS (2023)

Related references

Note: Only part of the references are listed.

Article Cell Biology

Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells

Matteo Zurlo et al.

Summary: Inhibitors of mTOR, such as Sirolimus, can enhance vaccine responses in the elderly. Testing Sirolimus and other geroprotective drugs might be a key strategy to improve the overall health resilience of aged populations. This study analyzed the activity of CD4(+) and CD8(+) T cells in beta-Thalassemia patients treated with Sirolimus and found that it positively impacted the biological activity and number of memory T cells.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)

Add to Collection

Article Virology

Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients

Wei-Chen Lee et al.

Summary: Liver transplant recipients were found to have low immunogenicity for anti-COVID-19 antibodies. Temporarily suspending the use of immunosuppressant drugs such as MMF or EVR during Moderna mRNA-1273 vaccination can facilitate antibody production. Factors such as temporary drug suspension and monotherapy were found to be favorable for generating a humoral response to the vaccine.

VIRUSES-BASEL (2023)

Add to Collection

Article Geriatrics & Gerontology

Evaluation of off-label rapamycin use to promote healthspan in 333 adults

Tammi L. Kaeberlein et al.

Summary: Rapamycin, an FDA-approved drug, has been shown in preclinical studies to extend lifespan and healthspan in various organisms. Some physicians are prescribing it off-label for preventative therapy, but there is limited data on its side effects or efficacy in this context. In this study, data was collected from adults who have used rapamycin off-label and compared to a group who have never used it, suggesting that rapamycin can be safely used in adults of normal health status.

GEROSCIENCE (2023)

Add to Collection

Article Surgery

mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients

Giuseppe S. Netti et al.

Summary: mTOR inhibitors (mTOR-I) treatment is associated with a better immune response to COVID-19 vaccine in kidney transplant recipients (KTR), not only by increasing vaccine-induced antibodies but also by stimulating anti-SARS-CoV-2 T cell response.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Article Medicine, Research & Experimental

Possible effects of sirolimus treatment on the long-term efficacy of COVID-19 vaccination in patients with β-thalassemia: A theoretical perspective Hypothesis and Theory

Matteo Zurlo et al.

Summary: The COVID-19 pandemic has been a challenge for global health, emphasizing the need for effective vaccines. Recent studies have shown that patients with beta-thalassemia have a high mortality rate from COVID-19, likely due to their immune deficiencies. Immunosuppression may also impact the effectiveness of COVID-19 vaccines, suggesting the use of immunomodulatory molecules as a potential solution.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Covid-19 Vaccine Effectiveness in New York State

Eli S. Rosenberg et al.

Summary: The effectiveness of the BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines in New York State from May to August 2021 was assessed. Initial protection was high, but there was a modest decline in effectiveness after the surge of the delta variant, especially among recipients aged 65 and older. However, protection against hospitalization remained high.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Immunology

Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients

Alessandra Mazzola et al.

Summary: The study found a low anti-spike antibody response to the BNT162b2 vaccine among solid organ transplant recipients, suggesting a need to change the vaccine strategy. Severe COVID-19 cases were reported in some recipients, but no serious adverse events were recorded.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Environmental Sciences

System dynamics analysis of COVID-19 prevention and control strategies

Shuwei Jia et al.

Summary: This study used system dynamics and causal loop analysis to establish a COVID-19 prevention and control model, identifying the multiple performances of strong supervision mode and its evolving effects in different stages. These findings provide a theoretical basis for improving epidemic prevention and control measures.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2022)

Add to Collection

Article Hematology

Immune response and adverse events after vaccination against SARS-CoV-2 in adult patients with transfusion-dependent thalassaemia

Polyxeni Delaporta et al.

Summary: Patients with transfusion-dependent thalassemia (TDT) can experience mild adverse events and generate protective antibodies comparable to the healthy population following vaccination with novel mRNA vaccines.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Article Immunology

Humoral immune response to Comirnaty (BNT162b2) SARS-Cov2 mRNA vaccine in Thalassemia Major patients

Emanuela Anastasi et al.

Summary: This study evaluated the humoral response to the Comirnaty vaccine in patients with Thalassemia Major (TM) and compared it with healthy blood donors (HBD). The results showed a similar serological response to the vaccine in both groups. Interestingly, asplenic patients had higher antibody titers, which may be related to splenectomy.

MICROBES AND INFECTION (2022)

Add to Collection

Letter Biology

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone

Chongsheng Cheng et al.

SCIENCE CHINA-LIFE SCIENCES (2022)

Add to Collection

Article Immunology

Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive Regimens

Silke E. de Boer et al.

Summary: Elderly kidney transplant recipients have a low immune response to COVID-19 vaccination, but an adjusted immunosuppressive regimen can improve the humoral response.

TRANSPLANTATION (2022)

Add to Collection

Article Immunology

Evaluation of SARS-CoV-2 Serum Level in Patients Vaccinated With Sinopharm/BBIBP-CorV With Kidney Transplantation

Maryam Rahbar et al.

Summary: The study found that kidney transplant patients treated with Rapamune showed increased IgM levels after receiving the COVID-19 vaccine, while no positive correlation was found between immunosuppressive drugs and IgG levels. Patients with a history of COVID-19 infection showed elevated levels of serum IgG/M after vaccination.

TRANSPLANTATION PROCEEDINGS (2022)

Add to Collection

Review Chemistry, Medicinal

Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks

Vincenzo Sorrenti et al.

Summary: Aging is a result of the dysregulation of multiple molecular pathways, with mTOR and AMPK signaling playing a role in cellular senescence. Poor nutritional balance is a driving factor in immunosenescence progression, and nutraceutical and pharmacological interventions can help maintain optimal biological response. Compounds like resveratrol, rapamycin, and metformin have shown positive effects in healthy aging.

PHARMACEUTICALS (2022)

Add to Collection

Letter Hematology

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

Rita Carsetti et al.

Summary: Patients with beta-thalassemia have a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection, making them a high-risk population. Vaccination is crucial in reducing mortality and morbidity for these frail patients. Limited data is available on the response of beta-thalassemia patients immunized with anti-SARS-CoV-2 mRNA vaccines.

BLOOD (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Overview of Research into mTOR Inhibitors

Beibei Mao et al.

Summary: The mammalian target of rapamycin (mTOR) is a crucial protein kinase involved in various cellular processes. Inhibitors of mTOR have shown antiviral, anti-inflammatory, and antiproliferative effects and have been applied in the research of different diseases.

MOLECULES (2022)

Add to Collection

Article Medicine, Research & Experimental

Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients

Matthew Tunbridge et al.

Summary: Kidney transplant recipients have a higher risk of severe COVID-19, but the effectiveness of vaccines in this population is reduced. This study aims to examine the effect of modifying immunosuppression prior to a third dose of COVID-19 vaccine to enhance vaccine response in kidney transplant recipients.

TRIALS (2022)

Add to Collection

Article Immunology

Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study

Athiphat Banjongjit et al.

Summary: Switching from the standard immunosuppressive regimen to mTORi, TAC, and prednisolone regimen enhances the immune response in kidney transplant recipients (KTRs) during COVID-19 vaccination.

VACCINES (2022)

Add to Collection

Article Hematology

Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)

Cristina Zuccato et al.

Summary: The study demonstrates that low-dose sirolimus treatment in patients with beta-thalassemia can increase the expression of gamma-globin genes and reduce biochemical markers associated with ineffective erythropoiesis. This finding provides important insights for the development of new therapeutic approaches.

THERAPEUTIC ADVANCES IN HEMATOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Waning Immunity after the BNT162b2 Vaccine in Israel

Yair Goldberg et al.

Summary: The immunity against the delta variant of SARS-CoV-2 waned in all age groups in Israel a few months after receiving the second dose of the vaccine, leading to an increase in infection and severe cases.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Hiam Chemaitelly et al.

Summary: In a study conducted in Qatar involving over 900,000 participants, vaccine effectiveness peaked at 77.5% in the first month after the second dose. However, it declined afterwards to as low as 20% in months 5 through 7 after vaccination, while protection against severe Covid-19 remained above 90% for at least 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Medicine, Research & Experimental

The 2020 race towards SARS-CoV-2 specific vaccines

Tomasz M. Karpinski et al.

Summary: The global outbreak of COVID-19 has emphasized the urgent need for effective vaccines and treatments. Advances in biotechnology and genetic engineering have provided progress in understanding the virus, with the development of vaccines being a key focus. Challenges in vaccine development and distribution, as well as the importance of safety and long-term effectiveness, have also been highlighted.

THERANOSTICS (2021)

Add to Collection

Article Hematology

Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study

Hongmin Li et al.

EXPERIMENTAL HEMATOLOGY (2020)

Add to Collection

Review Rheumatology

Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysis

Lanlan Ji et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)

Add to Collection

Article Respiratory System

The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis

Qi Wang et al.

RESPIRATORY RESEARCH (2020)

Add to Collection

Article Cell Biology

The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia

Christophe Lechauve et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Add to Collection

Letter Hematology

Additive effect of sirolimus and hydroxycarbamide on fetal haemoglobin level in kidney transplant patients with sickle cell disease

Adil A. Al-Khatti et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Add to Collection

Review Genetics & Heredity

β-Thalassemia

Raffaella Origa

GENETICS IN MEDICINE (2017)

Add to Collection

Article Surgery

Improved Fetal Hemoglobin With mTOR Inhibitor-Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease

N. Gaudre et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2017)

Add to Collection

Article Hematology

mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease

Jintao Wang et al.

BRITISH JOURNAL OF HAEMATOLOGY (2016)

Add to Collection

Review Hematology

Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches

Orapan Sripichai et al.

EXPERT REVIEW OF HEMATOLOGY (2016)

Add to Collection

Article Hematology

Rapamycin increases fetal hemoglobin and ameliorates the nociception phenotype in sickle cell mice

Alfia Khaibullina et al.

BLOOD CELLS MOLECULES AND DISEASES (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and beta-Thalassemia Patients

Alice Pecoraro et al.

HEMOGLOBIN (2015)

Add to Collection

Review Gastroenterology & Hepatology

Everolimus in de novo liver transplant recipients: a systematic review

Cheng-Yong Tang et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2015)

Add to Collection

Article Hematology

KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia

Dun Liu et al.

BLOOD (2014)

Add to Collection

Article Hematology

Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia

Khaled M. Musallam et al.

BLOOD (2012)

Add to Collection

Review Pharmacology & Pharmacy

Everolimus: efficacy and safety in cardiac transplantation

S. Allan Schaffer et al.

EXPERT OPINION ON DRUG SAFETY (2010)

Add to Collection

Article Genetics & Heredity

A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E

Manit Nuinoon et al.

HUMAN GENETICS (2010)

Add to Collection

Review Genetics & Heredity

Beta-thalassemia

Renzo Galanello et al.

ORPHANET JOURNAL OF RARE DISEASES (2010)

Add to Collection

Article Hematology

Effects of rapamycin on accumulation of α-, β- and γ-globin mRNAs in erythroid precursor cells from β-thalassaemia patients

Eitan Fibach et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2006)

Add to Collection

Review Genetics & Heredity

Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias

DJ Weatherall

NATURE REVIEWS GENETICS (2001)

Add to Collection

Review Pharmacology & Pharmacy

Sirolimus: A new agent for prevention of renal allograft rejection

EM Vazquez

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.